Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel J Stabley

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Nucleic Acids Research|February 13, 2003
A Ca2+-induced mitochondrial permeability transition causes complete release of rat liver endonuclease G activity from its exclusive location within the mitochondrial intermembrane space. Identification of a novel endo-exonuclease activity residing within the mitochondrial matrixAdrian M Davies, Stuart Hershman, Gabriel J Stabley, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
trans-3,4-dimethyl-4-(3-carboxamidophenyl)piperidines: a novel class of micro-selective opioid antagonistsBertrand Le Bourdonnec, Serge Belanger, Joel A Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
(4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligandsRoland E Dolle, Mathieu Machaut, Blanca Martinez-Teipel, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activityBertrand Le Bourdonnec, Christopher W Ajello, Pamela R Seida, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonistsGuo-Hua Chu, Minghua Gu, Joel A Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonistsKarin Worm, Damian G Weaver, Rosalyn C Green, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
CB2 selective sulfamoyl benzamides: optimization of the amide functionalityAllan J Goodman, Christopher W Ajello, Karin Worm, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Biaryl cannabinoid mimetics--synthesis and structure-activity relationshipKarin Worm, Q Jean Zhou, Gabriel J Stabley, et al.
Nucleic Acids Research|February 13, 2003
A Ca2+-induced mitochondrial permeability transition causes complete release of rat liver endonuclease G activity from its exclusive location within the mitochondrial intermembrane space. Identification of a novel endo-exonuclease activity residing within the mitochondrial matrixAdrian M Davies, Stuart Hershman, Gabriel J Stabley, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
trans-3,4-dimethyl-4-(3-carboxamidophenyl)piperidines: a novel class of micro-selective opioid antagonistsBertrand Le Bourdonnec, Serge Belanger, Joel A Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
(4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligandsRoland E Dolle, Mathieu Machaut, Blanca Martinez-Teipel, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activityBertrand Le Bourdonnec, Christopher W Ajello, Pamela R Seida, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Novel phenylamino acetamide derivatives as potent and selective kappa opioid receptor agonistsGuo-Hua Chu, Minghua Gu, Joel A Cassel, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonistsKarin Worm, Damian G Weaver, Rosalyn C Green, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
CB2 selective sulfamoyl benzamides: optimization of the amide functionalityAllan J Goodman, Christopher W Ajello, Karin Worm, et al.
Pageof 1